prostate. Herein we report a rare case of xanthogranulomatous prostatitis concurrent with benign prostatic hyperplasia. The exact cause of xanthogranulomatous prostatitis remains unknown. Xanthogranulomatous prostatitis…
Patients and Methods: The study included 58 patients with prostate cancer, 64 with benign prostatic hyperplasia (BPH), and 52 healthy controls. Full history and clinical data were recorded ... analyzed by…
patients were enrolled in the study. Of these patients, 28 were diagnosed with benign prostatic hyperplasia and 32 with prostate cancer, while 30 subjects were included as a control group ... regions were evaluated for…
This study investigates the incidence of IPC in operated specimens of patients with benign prostatic hyperplasia and their clinical behaviour. MATERIALS AND METHODS: Operated specimens (both Open Prostatectomy and…
glycoprotein produced as a marker by prostate gland for prostate cancer, benign prostate hyperplasia and prostatitis. Study objective is to evaluate f/t PSA ratio to distinguish the Benign Prostate ... Hyperplasia (BPH)…
section of pathology department and prepared reports. The preponderance of the cases was benign prostatic hyperplasia (63.2%), followed by prostatic carcinoma (28.9%), prostatic intraepithelial neoplasia (PIN) (1.3%)…
group was consisted of 35 subjects who had histopahtologically proven prostate cancer and benign prostatic hyperplasia. E-cadherin with a cut off value ... cadherin is more specific but was not available. Comparison of…
group comprising of 5 animals each, with individual rats weighing between 150g-320g. The prostatic hyperplasia was achieved by the simultaneous induction of 400ng/ml of Estradiol and 1250ng ... subjects from groups NC…
stolonifera etc.have been used traditionally and in modern medicines in the management of Benign prostatic hyperplasia (BPH) .BPH is an age dependent condition that affects old men. The condition ... converting…
There are many kinds of surgical treatment for benign prostatic hyperplasia (BPH). With the development of new methods and technologies, various surgical procedures have been developed for BPH. Such ... transurethral…
characterized the expression of SGLT1 in human prostate tissues: normal prostate (n=3), benign prostatic hyperplasia (BPH) (n=53), prostatic intraepithelial neoplasia (PIN) (n=9), and prostate cancer
ages of 70 to 79 years old. Other urological neoplasm such as Benign Prostatic Hyperplasia, Penile Cancer, Bladder Cancer, Kidney Cancer and Testicular cancer recorded the prevalence ... male gender starts to advance in…
transurethral resection of the prostate (TURP) as being the gold standard in treating benign prostatic hyperplasia (BPH). The proposed advantages of bipolar resection are improved haemostasis, better intraoperative…
africana species’ bark and bark extracts are used for the treatment of benign prostate hyperplasia. The pharmacological efficacy of the extracts is believed to be due to synergistic effect
rule on the Surgical Management of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign Prostatic Hyperplasia (BPH). Haematuria is blood in the pee. At the point when
extracted from 553 whole blood samples from 233 patients with LUTS resulted from benign prostatic hyperplasia and 320 control subjects. The IL-28B rs12979860 and rs8099917, and IL-28Rα rs10903035
medications specifically in patients with nocturnal urgency. Therapy for nocturia owing to benign prostatic hyperplasia includes a-blockers and 5a-reductase inhibitors, with variable outcomes. Future treatment for…
penis (13.5%), testis (7.0%) and scrotum. Among prostate lesions, maximum cases were of Benign Prostate Hyperplasia (82%) followed by adenocarcinoma (11.6%) and in penile lesions maximum cases were of squamous
trypsin inhibitor heavy chain 4, saposin B and bikunin compared to patients with benign prostatic hyperplasia. Currently, diagnosis of prostate cancer is very much reliant on the levels of serum ... biopsy, the…
different TNM stages. We enrolled 54 patients with prostate cancer, 40 with benign prostatic hyperplasia, and 20 subjects with normal prostates. S100P, CD147, and OCT4 were detected by immunohistochemistry ... detection…
underwent prostate biopsy, and showed no evidence of cancer with or without indication of prostatic hyperplasia, or had a definitive pathology diagnosis of prostatic adenocarcinoma. Probit linear regression models were…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.